MECHANISMUS DER POLAROGRAPHISCHEN REDUKTION VON S,S-DIPHENYLSULFOXIMINEN = MECANISME DE LA REDUCTION POLAROGRAPHIQUE DE S,S-DIPHENYL SULFOXIMIDESHOFFMANN H; GESCHER A.1973; ARCH. PHARM.; DTSCH.; DA. 1973; VOL. 306; NO 7; PP. 492-499; ABS. ANGL.; BIBL. 10 REF.Serial Issue

Antiproliferative properties of phorbol ester tumour promotersGESCHER, A.Biochemical pharmacology. 1985, Vol 34, Num 15, pp 2587-2592, issn 0006-2952Article

Metabolism of N,N-dimethylformamide : key to the understanding of its toxicityGESCHER, A.Chemical research in toxicology. 1993, Vol 6, Num 3, pp 245-251, issn 0893-228XArticle

STUDIES OF THE METABOLISM OF N-METHYL CONTAINING ANTI-TUMOUR AGENTS. ¹⁴CO₂ BREATH ANALYSIS AFTER ADMINISTRATION OF ¹⁴C-LABELLED N-METHYL DRUGS, FORMALDEHYDE AND FORMATE IN MICEGESCHER A; RAYMONT C.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 11; PP. 1245-1252; BIBL. 23 REF.Article

Analogs of staurosporine : Potential anticancer drugs?GESCHER, A.General pharmacology. 1998, Vol 31, Num 5, pp 721-728, issn 0306-3623Article

DRUG METABOLISM INTERACTIONS WITH ANTICANCER AGENTS IN MICEGREEN AE; GESCHER A.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 2; PP. 131-136; BIBL. 23 REF.Article

ANTITUMOR ACTIVITY, BIOMIMETIC OXIDATION AND METABOLISM OF HETEROALICYCLIC TRIAZENESSTEVENS MFG; GESCHER A; TURNBULL CP et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 6; PP. 769-776; BIBL. 23 REF.Article

TRIAZINES AND RELATED PRODUCTS. XVIII. DECOMPOSITION OF 1,2,3-BENZOTRIAZINES AND RELATED TRIAZENES WITH SODIUM AZIDE IN ACETIC ACID: A CONVENIENT ROUTE TO AZIDOARENES.GESCHER A; STEVENS MFG; TURNBULL CP et al.1977; J. CHEM. SOC., PERKIN TRANS.; G.B.; DA. 1977; NO 2; PP. 103-106; BIBL. DISSEM.Article

TRIAZINES AND RELATED PRODUCTS. XIX. 4-AMINO 2-(2-(PIPERIDIN-1-YLAZO)-PHENYL) QUINAZOLINE AND ITS ANALOGUES.GESCHER A; STEVENS MFG; TURNBULL CP et al.1977; J. CHEM. SOC., PERKIN TRANS.; G.B.; DA. 1977; NO 2; PP. 107-114; BIBL. DISSEM.Article

TRIAZINES AND RELATED PRODUCTS. XX. OXIDATION OF 1-(ARYLAZO)-PIPERIDINES WITH POTASSIUM PERMANGANATE.GESCHER A; TURNBULL CP; STEVENS MFG et al.1977; J. CHEM. SOC., PERKIN TRANS., 1; G.B.; DA. 1977; NO 18; PP. 2078-2083; BIBL. 17 REF.Article

Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cellsDALE, I. L; GESCHER, A.International journal of cancer. 1989, Vol 43, Num 1, pp 158-163, issn 0020-7136Article

Characterization of the growth inhibition induced by tumor-promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cellsGESCHER, A; REED, D. J.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4315-4321, issn 0008-5472Article

ASSESSMENT OF RENAL FUNCTION DURING HIGH-DOSE CIS-PLATINUM THERAPY IN PATIENTS WITH OVARIAN CARCINOMABUAMAU PK; HOWELL A; WHITBY H et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 3; PP. 281-284; BIBL. 14 REF.Article

STUDIES OF THE MODE OF ACTION OF ANTITUMOUR TRIAZENES AND TRIAZINES. II: INVESTIGATION OF THE SELECTIVE TOXICITY OF 1-ARYL-3,3-DIMETHYLTRIAZENESGESCHER A; HICKMAN JA; SIMMONDS RJ et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 1; PP. 89-93; BIBL. 14 REF.Article

N-HYDROXYMETHYLPENTAMETHYLMELAMINE, A MAJOR IN VITRO METABOLITE OF HEXAMETHYLMELAMINEGESCHER A; D'INCALCI M; FANELLI R et al.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 2; PP. 147-154; BIBL. 14 REF.Article

ALPHA -HYDROXYLATED DERIVATIVES OF ANTITUMOUR DIMETHYLTRIAZENESGESCHER A; HICKMAN JA; SIMMONDS RJ et al.1978; TETRAHEDRON LETTERS; GBR; DA. 1978; NO 50; PP. 5041-5044; BIBL. 11 REF.Article

STEREOSELECTIVITY OF THE DISTRIBUTION OF LABELLED NORADRENALINE IN RABBIT AORTIC STRIPS AFTER INHIBITION OF THE NORADRENALINE-METABOLIZING ENZYMESECKERT E; HENSELING M; GESCHER A et al.1976; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1976; VOL. 292; NO 3; PP. 219-229; BIBL. 11 REF.Article

Modulators of signal transduction as cancer chemotherapeutic agents - novel mechanisms and toxicitiesGESCHER, A.Toxicology letters. 1995, Vol 82-83, pp 159-165, issn 0378-4274Conference Paper

Staurosporine analogues - pharmacological toys or useful antitumour agents?GESCHER, A.Critical reviews in oncology/hematology. 2000, Vol 34, Num 2, pp 127-135, issn 1040-8428Article

Denitrification of the genotoxicant 2-nitropropane : relationship to its mechanism of toxicityKOHL, C; GESCHER, A.Xenobiotica (London. Print). 1997, Vol 27, Num 8, pp 843-852, issn 0049-8254Article

The role of pharmacokinetic and metabolism studies in anticancer drug discovery and developmentGESCHER, A; NEWELL, D. R.Progress in drug metabolism. 1992, Vol 13, pp 263-294, issn 0364-8974Article

Analysis of decomposition products of alkyl nitronic acids by reversed-phase high-performance liquid chromatographySHAW, A. J; GESCHER, A.Journal of chromatography. 1990, Vol 505, Num 2, pp 402-407, issn 0021-9673, 6 p.Article

Protein kinase C. A novel target for rational anti-cancer drug design?GESCHER, A; DALE, I. L.Anti-cancer drug design. 1989, Vol 4, Num 2, pp 93-105, issn 0266-9536Article

The metabolism of triazene antitumor drugsGESCHER, A; THREADGILL, M. D.Pharmacology & therapeutics (Oxford). 1987, Vol 32, Num 2, pp 191-205, issn 0163-7258Article

N-METHYLFORMAMIDE: ANTITUMOUR ACTIVITY AND METABOLISM IN MICEGESCHER A; GIBSON NW; HICKMAN JA et al.1982; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1982; VOL. 45; NO 6; PP. 843-850; BIBL. 26 REF.Article